Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Connective and Soft Tissue Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002167
What this trial is testing

Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.

Who this might be right for
Sarcoma, KaposiHIV Infections
Clinical Solutions 78
Large-scale testing (Phase 3)Study completedNCT01581944
What this trial is testing

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

Who this might be right for
Fibroids
Mt. Hope Maternity Hospital 68
Not applicableLooking for participantsNCT06111612
What this trial is testing

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Not applicableStudy completedNCT00001120
What this trial is testing

Patients With AIDS Syndrome

Who this might be right for
Sarcoma, KaposiLymphoma, Non-HodgkinHIV Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 5,000
Not applicableNo Longer AvailableNCT01427582
What this trial is testing

YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access

Who this might be right for
Soft Tissue Sarcoma
University of Texas Southwestern Medical Center
Testing effectiveness (Phase 2)Study completedNCT00330421
What this trial is testing

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Who this might be right for
Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorMetastatic OsteosarcomaRecurrent Adult Soft Tissue Sarcoma+6 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT01896778
What this trial is testing

Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Who this might be right for
Adult Liver CarcinomaBreast CarcinomaColon Carcinoma+7 more
Roswell Park Cancer Institute 9
Early research (Phase 1)UnknownNCT05415098
What this trial is testing

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Who this might be right for
Nasopharyngeal CarcinomaCastrate Resistant Prostate CancerGastric Cancer+6 more
Ascentage Pharma Group Inc. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03141684
What this trial is testing

Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

Who this might be right for
Metastatic Alveolar Soft Part SarcomaUnresectable Alveolar Soft Part Sarcoma
National Cancer Institute (NCI) 63
Not applicableStudy completedNCT01229826
What this trial is testing

Magnetic Resonance Elastography (MRE) of Uterine Fibroids

Who this might be right for
Uterine Fibroids
Mayo Clinic 134
Testing effectiveness (Phase 2)Study completedNCT04067115
What this trial is testing

SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients

Who this might be right for
Ewing Sarcoma
Sarcoma Alliance for Research through Collaboration 37
Not applicableStudy completedNCT06397443
What this trial is testing

Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy

Who this might be right for
Multiple OsteochondromaOllier DiseaseOsteogenesis Imperfecta
Istituto Ortopedico Rizzoli 8
Testing effectiveness (Phase 2)Study completedNCT01055314
What this trial is testing

Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal Rhabdomyosarcoma+3 more
National Cancer Institute (NCI) 175
Not applicableUnknownNCT02443948
What this trial is testing

Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Fondazione del Piemonte per l'Oncologia 60
Testing effectiveness (Phase 2)UnknownNCT05265793
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma

Who this might be right for
PD-1 ImmunotherapyVEGFR-TKISarcomatoid Carcinoma+1 more
Fudan University 45
Testing effectiveness (Phase 2)Ended earlyNCT00958893
What this trial is testing

An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext

Who this might be right for
Uterine Fibroids
Repros Therapeutics Inc. 4
Early research (Phase 1)Ended earlyNCT00573404
What this trial is testing

Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Gastrointestinal Stromal Tumor
Vanderbilt-Ingram Cancer Center 6
Not applicableLooking for participantsNCT07328178
What this trial is testing

Analysis of the Role of IgE Proteoforms in Health and Disease

Who this might be right for
AnaphylaxisMastocytosisX-linked Agammaglobulinaemia+6 more
KU Leuven 200
Very early researchLooking for participantsNCT07628634
What this trial is testing

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Who this might be right for
AdenocarcinomaBasal Cell CarcinomaSquamous Cell Carcinoma+12 more
University of California, Irvine 25
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Next Page